| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/MUS.21739 |
| P953 | full work available at URL | https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmus.21739 |
| https://onlinelibrary.wiley.com/doi/pdf/10.1002/mus.21739 | ||
| P698 | PubMed publication ID | 20740627 |
| P2093 | author name string | Bahija Jallal | |
| Chris Morehouse | |||
| Mohammad Salajegheh | |||
| Yihong Yao | |||
| Anthony A. Amato | |||
| Steven A. Greenberg | |||
| Jack L. Pinkus | |||
| P2860 | cites work | BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma | Q24646563 |
| Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position | Q28205590 | ||
| BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseases | Q28205999 | ||
| Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis | Q28246912 | ||
| A local antigen-driven humoral response is present in the inflammatory myopathies | Q33267230 | ||
| Interferon-stimulated gene 15 (ISG15) conjugates proteins in dermatomyositis muscle with perifascicular atrophy | Q33534742 | ||
| Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis | Q33611035 | ||
| Inclusion body myositis and myopathies | Q34289237 | ||
| IMGT/V-QUEST, an integrated software program for immunoglobulin and T cell receptor V-J and V-D-J rearrangement analysis | Q35556713 | ||
| Lymphoid neogenesis in chronic inflammatory diseases. | Q36405080 | ||
| Proposed immunologic models of the inflammatory myopathies and potential therapeutic implications | Q40165239 | ||
| Thyroid autoimmune disease: demonstration of thyroid antigen-specific B cells and recombination-activating gene expression in chemokine-containing active intrathyroidal germinal centers | Q41873772 | ||
| Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies. | Q46483118 | ||
| Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren's syndrome | Q47389814 | ||
| Visualization of specific B and T lymphocyte interactions in the lymph node | Q47892330 | ||
| Stochastic models inspired by hybridization theory for short oligonucleotide arrays. | Q48477597 | ||
| Peripheral lymphoid tissue-like adhesion molecule expression in nodular infiltrates in inflammatory myopathies | Q49167017 | ||
| Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. | Q51027456 | ||
| Myeloid dendritic cells in inclusion-body myositis and polymyositis. | Q53599681 | ||
| Plasma cells in muscle in inclusion body myositis and polymyositis. | Q53644502 | ||
| Molecular profiles of inflammatory myopathies. | Q54145481 | ||
| 119th ENMC international workshop: Trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The Netherlands | Q57752724 | ||
| Expression of the B cell-attracting chemokine CXCL13 in the target organ and autoantibody production in ectopic lymphoid tissue in the chronic inflammatory disease Sjögren's syndrome | Q60548220 | ||
| Extranodal lymphoid microstructures in inflamed muscle and disease severity of new-onset juvenile dermatomyositis | Q83586489 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | myositis | Q1433212 |
| cellular senescence | Q9075999 | ||
| P304 | page(s) | 576-583 | |
| P577 | publication date | 2010-10-01 | |
| P1433 | published in | Muscle and Nerve | Q15764281 |
| P1476 | title | Permissive environment for B-cell maturation in myositis muscle in the absence of B-cell follicles | |
| Permissive environment for B‐cell maturation in myositis muscle in the absence of B‐cell follicles | |||
| P478 | volume | 42 |
| Q34667765 | An overview of polymyositis and dermatomyositis |
| Q55040612 | Architectural B-cell organization in skeletal muscle identifies subtypes of dermatomyositis. |
| Q33918389 | Autoantibodies against a 43 KDa muscle protein in inclusion body myositis |
| Q34447370 | Autoantibodies produced at the site of tissue damage provide evidence of humoral autoimmunity in inclusion body myositis |
| Q34675925 | Cytosolic 5'-nucleotidase 1A autoimmunity in sporadic inclusion body myositis. |
| Q36842564 | Differential roles of hypoxia and innate immunity in juvenile and adult dermatomyositis |
| Q30235935 | Ectopic lymphoid neogenesis in rheumatic autoimmune diseases |
| Q34528042 | Expression of BAFF receptors in muscle tissue of myositis patients with anti-Jo-1 or anti-Ro52/anti-Ro60 autoantibodies |
| Q42071747 | From innate to adaptive immune response in muscular dystrophies and skeletal muscle regeneration: the role of lymphocytes |
| Q34484782 | Genomic signatures characterize leukocyte infiltration in myositis muscles. |
| Q36926351 | Idiopathic inflammatory myopathies: pathogenic mechanisms of muscle weakness |
| Q33753870 | Immune and myodegenerative pathomechanisms in inclusion body myositis |
| Q54645632 | Inclusion body myositis pathogenesis: Steady progress. |
| Q92150187 | Inclusion body myositis: clinical features and pathogenesis |
| Q43978656 | New aspects on the pathogenesis of myositis |
| Q46195557 | Seropositivity for NT5c1A antibody in sporadic inclusion body myositis predicts more severe motor, bulbar and respiratory involvement |
| Q52667738 | Serum BAFF in Indian patients with IIM: a retrospective study reveals novel clinico-phenotypic associations in children and adults. |
| Q38767200 | Sporadic inclusion body myositis - a myodegenerative disease or an inflammatory myopathy |
| Q64892811 | T Follicular Helper-Like Cells in Inflamed Non-Lymphoid Tissues. |
| Q38070033 | T cells in myositis |
| Q86958025 | The V(H) repertoire and clonal diversification of B cells in inflammatory myopathies |
| Q35450066 | The tumor necrosis factor superfamily of cytokines in the inflammatory myopathies: potential targets for therapy. |
Search more.